AnBrasDermatol.2020;95(5):645---648
Anais
Brasileiros
de
Dermatologia
www.anaisdedermatologia.org.brIMAGES
IN
DERMATOLOGY
Multisystemic
fusariosis
with
fulminant
evolution
夽,夽夽
Nelson
Turra
a,∗,
Agustina
Acosta
b,
Andrea
Incoronato
c,
Pilar
Beltramo
daDepartmentofDermatology,Dr.ManuelQuintelaClinicalHospital,Montevideo,Uruguay bDepartmentofPediatricDermatology,PereiraRossellHospital,Montevideo,Uruguay cDepartmentofHemato-oncology,PereiraRossellHospital,Montevideo,Uruguay dDepartmentofPathology,PereiraRossellHospital,Montevideo,Uruguay
Received15August2019;accepted5March2020 Availableonline12July2020
KEYWORDS Bacterialinfections andmycoses; Bonemarrow transplantation; Centralnervous systemfungal infections; Fusariosis; Fusarium
Abstract Thisreportpresentsthecaseofa13-year-oldfemalepatientwithhistoryofacute myeloid leukemia, who,after abone marrow transplant, began to vomit andexperienced rapidlyprogressivedeteriorationofconsciousness,inadditiontodisseminated erythematous-violaceousmacules,andsomeblisterswithhemorrhagiccontentinside.Skinbiopsyevidenced intravascularfilamentousstructures.AbloodcultureconfirmedthepresenceofFusarium oxys-porum.Intravenoustreatmentwithvoriconazolewasinitiated.Thepatientevolvedunfavorably withmultiplenecroticskinlesions,ischemicbrainlesions,anddeath.
©2020SociedadeBrasileira deDermatologia.PublishedbyElsevierEspa˜na,S.L.U.Thisisan openaccessarticleundertheCCBYlicense(http://creativecommons.org/licenses/by/4.0/).
Introduction
Fusarium spp. arefungi universally found in soil, air, and
plants; they mainly affect immunocompromised patients
夽 Howtocitethisarticle:TurraN,AcostaA,IncoronatoA, Bel-tramoP.Multisystemicfusariosiswithfulminantevolution.AnBras Dermatol.2020;95:645---8.
夽夽StudyconductedatthePereiraRossellHospital,Montevideo, Uruguay.
∗Correspondingauthor.
E-mail:nelsonturra85@gmail.com(N.Turra).
and may cause localized, focally invasive, or
dissemi-nateddisease.1,2Immunosuppressedpatientsandcarriersof
hematologicmalignanciesareverysusceptibletothe
devel-opmentof invasive forms, showing high mortality.2---4 This
reportdescribesthecase of apatientwithacutemyeloid
leukemia,whopresented withinvasivefusariosiswith
ful-minantevolutionafterabonemarrowtransplant.
Case
report
13-year-oldadolescent,female,whopresentedthreeyears
agowithacutemyeloblasticleukemia,achievingcomplete
remissionofherdisease.Shepresentedherfirst
hematologi-https://doi.org/10.1016/j.abd.2020.03.007
0365-0596/©2020SociedadeBrasileiradeDermatologia.PublishedbyElsevierEspa˜na,S.L.U.ThisisanopenaccessarticleundertheCC BYlicense(http://creativecommons.org/licenses/by/4.0/).
646 TurraNetal.
calrelapsethreemonthsago,thenachievedanewcomplete
remission,and underthese conditionsan allogeneic bone
marrow transplant (BMT) was planned. Myelosuppressive
conditioningwasperformedwithbusulfanandfludarabine,
administeredtogetherwithan infectious prophylaxis with
acyclovir,trimethoprim-sulfamethoxazole,andfluconazole.
Afterfivedaysofthetransplant,administrationof
granu-locytecolony-stimulating factor was initiated (Neupogen®
300g/kg/day).
After aweek of BMT,the patientbegan to experience
headache and vomiting, showing central facial paralysis
andrapidlyprogressivedeteriorationofconsciousness,until
reachingascoreof7according totheGlasgowScale;this
motivated her admission to the Intensive Care Unit. The
antibiotic treatment was adjusted to a broad spectrum
scheme with meropenem 60mg/kg/day and vancomycin
40mg/kg/day. At that time, an interconsultation with a
dermatologist wasperformed, due to thesudden
appear-ance of multiple disseminated skin lesions. On physical
examination,shepresenteddisseminateddermatosisonthe
trunk, lower, and upper limbs, characterized by rounded
erythematous-violaceousmacules,infiltratedonpalpation,
andsomeblisterswithhemorrhagiccontentinside(Fig.1).
Laboratory tests showed hemoglobin of 9.4mg/dL; 2,800
mm3 leukocytes (60% neutrophils); 53,000mm3 platelets,
withnormalliverandkidneyfunction.Bloodcultureswere
negative.Also,polymerasechainreactionwasnegativefor
cytomegalovirus,varicellazostervirus,andherpessimplex
virustypes1and2.
The skin biopsy was processed for staining with
hematoxylin-eosin, PAS, and Grocott-Gomori; evidencing
intraepidermal acantholysis, vessels with fibrinoid
necro-sisof thewall, andocclusive thrombosis.The biopsy also
foundsuperficialperivascular inflammatoryinfiltrate
com-posed of lymphocytes, neutrophils, and leukocytoclasia,
highlightingthepresenceofintravascularfilamentous
struc-tures,correspondingtoseptate hyphae andconidiospores
(Figs.2---4).Asubsequentbloodcultureconfirmedthe pres-enceof Fusarium oxysporum, and treatment was started
withintravenous voriconazole4mg/kg/dose,twice a day.
Thepatientevolvedunfavorablyandwithskinlesionsthat
adopteda centralnecroticappearancewithascaling
col-Figure 1 Invasive fusariosis, early clinical manifestations (left thigh). Dermatosis characterized by the presence of erythematous-violaceousmacules,whichcoexisttogetherwith hemorrhagicblisters,situatedonerythematousandinfiltrated skin.
Figure 2 Fusariosis, histopathology of skin lesions (Hema-toxylin & eosin, ×40). Vessels with fibrinoid wall necrosis and occlusive thrombosis in their lumens, accompanied by a superficial perivascular inflammatory infiltrate composed of lymphocytes, neutrophils, and leukocytoclasia. The yel-lowarrowhighlightsthepresenceofintravascularfilamentous structures,correspondingtoseptatehyphae.
Figure3 Fusariosis,histopathologyofskinlesions(PAS,×40). Septatehyphaeandintravascularconidiophoresareevident.
larette (Fig. 5). Subsequently, she began to suffer from
severe diabetes insipidus (hypernatremia crisis of up to
170 mEq/L). Magnetic resonance of the brain, taken 20
dayspost-transplant,evidencedthepresenceof extensive
ischemiclesionsandcerebraledema,withtonsillar
hernia-tionandbulbo-spinalcompression.Afterthreeweeksofthe
transplant,thepatientdied.
Discussion
Fusariumspp.arefungipresentinthesoilinallpartsofthe
world,includingtropical,desert, andevenarcticregions;
thisis duetotheir highadaptability.Regarding their
inci-dence,theycorrespondstothesecondmostfrequentcause
of invasivemoldinfectioninhemato-oncological patients,
behindAspergillusspp.5Theriskfactorsforinvasive
Multisystemicfusariosiswithfulminantevolution 647
Figure4 Fusariosis,histopathologyofskinlesions (Grocott-Gomori,×40).Septatehyphaeandintravascularconidiophores areevident.
Figure 5 Invasive fusariosis, late clinical manifestations (right arm). Dermatosis characterized by the presence of necroticskinlesionswithscalingcollarette.
induction chemotherapy for leukemia, recent BMT, and
graft vs. host disease.1,6 Likewise, the authors highlight
that the current patient was a carrier of acute myeloid
leukemiaand hadrecentlyreceived aBMT. Itis expected
thatafteraBMT,severeneutropeniawilloccur,inthe
con-textofthemyelosuppressiveconditioningrequiredforthis
procedure.
Invasiveformsoffusariosisshowcutaneousinvolvement
in 63% of cases, and this is characterized by the
pres-ence of subcutaneous nodules, erythematous macules, or
vesicle-pustulesthatmaybecomenecrotic.4,7Thispathogen
is highly angio-invasive, producing tissue infarctions such
as those evidenced in the brain of the current patient,
whichgenerateintravascularsporulation,favoringagreater
sensitivity of blood cultures in the final stages of the
disease.8 Fusarium spp. are resistant tomultiple
antifun-gals, but are highly susceptible to amphotericin B and
voriconazole.1,9,10However,severeneutropeniaisthemost
importantprognosticfactor,determininglethalityofupto
75%ofcases.6,10
Final
considerations
Invasivefusariosisisextremelyseriousandisassociatedwith
high mortality in immunosuppressed patients. It requires
intensiveantifungaltreatmentandadministrationof
gran-ulocyte colony stimulating factor, since its prognosis is
closely related to the recovery of neutropenia. The role
of the dermatologist as part of a multidisciplinary team
mustbeemphasized,havingahighdiagnosticsuspicionof
this pathology in the case of immunosuppressed patients
withclinicalmanifestationssimilartothosepreviously
elu-cidated.
Financial
support
Nonedeclared.
Authors’
contributions
NelsonTurra:Approvalofthefinalversionofthemanuscript;
draftingandeditingofthemanuscript;participationinstudy
design;participationinthetherapeuticand/or
propaedeu-tic conduct of the studied cases; critical review of the
literature;criticalreviewofthemanuscript.
Agustina Acosta: Approval of the final version of the
manuscript;participationin study design; participationin
thetherapeuticand/or propaedeuticconductofthe
stud-iedcases;criticalreviewoftheliterature;criticalreviewof
themanuscript.
Andrea Incoronato:Approvalof thefinalversion ofthe
manuscript;participationin study design; participationin
thetherapeuticand/orpropaedeuticconductofthestudied
cases;criticalreviewoftheliterature;criticalreviewofthe
manuscript.
Pilar Beltramo: Approval of the final version of the
manuscript;participationin study design; participationin
thetherapeuticand/or propaedeuticconductofthe
stud-iedcases;criticalreviewoftheliterature;criticalreviewof
themanuscript.
Conflicts
of
interest
Nonedeclared.
References
1.TanaseA,ColitaA,IanosiG,NeagoeD,BranisteanuDe,Calina D,etal.Rarecaseofdisseminatedfusariosisinayoungpatient withgraftvs.hostdiseasefollowinganallogeneictransplant. ExpTherMed.2016;12:2078---82.
2.García-Ruiz J, Olazábal I, Adán Pedroso R, López-Soria L, Velasco-Benito V, Sánchez-Aparicio J, et al. Disseminated fusariosis and hematologic malignancies, a still devastating association. Report of three new cases. Rev Iberoam Micol. 2015;32:190---6.
3.NucciF,NouérSA,CaponeD,AnaissieE,NucciM.Fusariosis. SeminRespirCritCareMed.2015;36:706---14.
648 TurraNetal.
4.HayashidaMZ,SequeCA,EnokiharaMMSES,PorroAM. Dissem-inated fusariosiswith cutaneousinvolvement in hematologic malignancies:reportofsixcaseswithhighmortalityrate.An BrasDermatol.2018;93:726---9.
5.Delia M,MonnoR, GiannelliG, Ianora Aa,DalfinoL, Pastore D,etal.Fusariosisinapatientwithacutemyeloidleukemia: a case reportand review of theliterature. Mycopathologia. 2016;181:457---63.
6.Al-Hatmi AM, Hagen F, Menken SB, Meis JF, de Hoog GS. Global molecular epidemiology and genetic diversity of Fusarium, a significant emerging group of human oppor-tunists from 1958 to 2015. Emerg Microbes Infect. 2016;5: e124.
7.SchwartzKL,SheffieldH,RichardsonSE,SungL,MorrisSK. Inva-sivefusariosis:asinglepediatriccenter15-yearexperience.J PediatrInfectDisSoc.2015;4:163---70.
8.BergerAP, FordBA, Brown-JoelZ, ShieldsBE,Rosenbach M, WanatKA.Angioinvasivefungalinfectionsimpactingtheskin: diagnosis,management,andcomplications.JAmAcad Derma-tol.2019;80:883---98.
9.GóralskaK,BlaszkowskaJ,DzikowiecM.Neuroinfectionscaused byfungi.Infection.2018;46:443---59.
10.ArnoniMV,PaulaCR,AulerME,SimõesCCN,NakanoS,Szeszs MW,etal.InfectionscausedbyFusariumspeciesinpediatric cancer patients and review of published literature. Myco-pathologia.2018;183:941---9.